DuChemBIO Co.,Ltd. (KOSDAQ:176750)

South Korea flag South Korea · Delayed Price · Currency is KRW
9,520.00
-410.00 (-4.13%)
At close: Mar 19, 2026
Market Cap274.94B -18.8%
Revenue (ttm)37.25B +7.3%
Net Income7.74B +93.5%
EPS274.60 +83.6%
Shares Out28.34M
PE Ratio35.32
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume19,279
Average Volume112,714
Open9,840.00
Previous Close9,930.00
Day's Range9,520.00 - 9,860.00
52-Week Range8,360.00 - 14,950.00
Beta0.03
RSI47.07
Earnings DateMar 27, 2026

About DuChemBIO

DuChemBIO Co.,Ltd. engages in the development, production, and sale of radiopharmaceutical products for cancer diagnosis and treatment in South Korea. Its products include FP-CIT for diagnosis of Parkinson’s disease and Parkinson's syndrome by measuring the density of dopamine transporters present in the brain striatum; F-DOPA for brain tumor diagnosis with neutralization technology; Neuraceq for diagnosis of Alzheimer's disease by measuring the distribution and density of beta amyloid in the brain; and Vizamyl for early diagnosis of beta amylo... [Read more]

Industry Orthopedic, Prosthetic, and Surgical Appliances and Supplies
Founded 2002
Employees 126
Stock Exchange KOSDAQ
Ticker Symbol 176750
Full Company Profile

Financial Performance

Financial Statements